UPL Share Price Up by 4.78%; Revenue Grows 9% YoY in Q2 FY 2025 Financial Results

UPL Limited reported financial results for the quarter and half year ended September 30, 2024. 

After the results announcement, on November 12, 2024, UPL share price opened at ₹530.00, up from its previous close of ₹515.15. At 9:33 AM, the share price of UPL was trading at ₹539.75, up by 4.78%.

Q2 FY 2025 Financial Highlights

In Q2 FY25, the company reported a revenue of ₹11,090 crore, reflecting a 9% increase from ₹10,170 crore in Q2 FY24. Contribution profit also rose slightly to ₹4,180 crore, marking a 3% increase from ₹4,060 crore in the same quarter last year. 

Meanwhile, EBITDA for the quarter stood nearly flat at ₹1,576 crore, with a margin of 14.2%, down by 130 basis points from the 15.5% margin recorded in the prior year. The company reported a net loss of ₹443 crore in Q2 FY25. 

H1 FY 2025 Financial Highlights

For the half-year ended September 30, 2024 (H1 FY25), revenue reached ₹20,157 crore, up 5% from ₹19,133 crore in H1 FY24. Despite the revenue growth, contribution profit declined by 5% to ₹7,764 crore. 

EBITDA for H1 FY25 dropped by 14% to ₹2,721 crore, resulting in a reduced EBITDA margin of 13.5% compared to 16.6% in H1 FY24. The company reported a net loss of ₹827 crore for H1 FY25.

Commenting on the performance, the CEO of UPL Corporation Ltd, Mike Frank, stated, “The fundamentals in the global crop protection market continue to remain strong. We continue to see robust dealer and farmgate demand across most regions for our products, as seen in our 13% volume growth this past quarter. Leading this growth was our fungicide segment, led by mancozeb products globally, as well as other premium fungicides in Europe.”

He further added, “We had continued growth in our BioSolutions NPP business, which grew 10%. Specifically, our biocontrol offerings in Latin America and Europe have received strong customer demand. Additionally, NPP was supported by biostimulant volumes in Brazil.”

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.